Effects of sotagliflozin combined with intensive insulin therapy in young adults with poorly controlled type 1 diabetes: The JDRF Sotagliflozin Study
Bode BW, Cengiz E, Wadwa RP, et al.
Diabetes Technol Ther. 2021;23(1):59-69.
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Bode BW, Cengiz E, Wadwa RP, et al.
Diabetes Technol Ther. 2021;23(1):59-69.
Leggi
Wong ND, Zhao Y, Sung J, Browne A
Am J Cardiol. 2021;S0002-9149(21)00031-X
Leggi
Palmer SC, Tendal B, Mustafa RA, et al.
BMJ 2021;372:m4573
Leggi
Bergenstal RM, Nimri R, Beck RW, et al.
Lancet. 2021;397(10270):208-219.
Leggi
Jensen J, Omar M, Kistorp C, et al.
Lancet Diabetes Endocrinol. 2020;S2213-8587(20)30382-X.
Leggi
Levey AS, Eckardt KU, Dorman NM, et al.
Eur Heart J. 2020;41(48):4592-98
Leggi
Fleming N, Sacks LJ, Pham C, et al.
Diabet Med. 2020;e14509
Leggi
Wheeler DC, Stefánsson BV, Jongs N, et al.
Lancet Diabetes Endocrinol. 2021;9(1):22-31
Leggi
Ciardullo S, Monti T, Perseghin G
Diabetes Care. Pub. online 10 December 2020
Leggi
Parkkola A, Turtinen M, Härkönen T, et al.
Diabetologia. Pub. online 17 December 2020
Leggi